KUALA LUMPUR (Sept 28): Bintai Kinden Corp Bhd sai
Post# of 36568
(Total Views: 320)
Posted On: 09/28/2020 12:28:07 PM
KUALA LUMPUR (Sept 28): Bintai Kinden Corp Bhd said it today entered into a memorandum of understanding (MOU) with Institut Jantung Negara Sdn Bhd (IJN) to explore a possible collaboration in the commercial development of Covid-19 vaccine in Malaysia based on an existing partnership between Bintai Kinden and US-based Generex Biotechnology Corp.
In a statement to Bursa Malaysia today, Bintai Kinden said it is partnering Generex to commercialise the Ii-Key-SARS-CoV-2 coronavirus vaccine in Malaysia.
IJN is also known as the National Heart Institute, which specialises in cardiovascular and thoracic medicine, according to its website.
In a statement to Bursa Malaysia today, Bintai Kinden said it is partnering Generex to commercialise the Ii-Key-SARS-CoV-2 coronavirus vaccine in Malaysia.
IJN is also known as the National Heart Institute, which specialises in cardiovascular and thoracic medicine, according to its website.
(1)
(0)